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Results {#sec1}
=======

Simultaneous Induction of *TMO5/LHW* Results in Cell Proliferation {#sec1.1}
------------------------------------------------------------------

To dissect the transcriptional responses downstream of TMO5/LHW, we generated a double dexamethasone (DEX)-inducible line by fusing TMO5 and LHW to the glucocorticoid receptor (GR) tag and driving them from the strong meristematic *RPS5A* promoter \[[@bib10]\]. As expected, the number of cell files (quantified as total number of cell files in radial sections halfway between the quiescent center and the elongation zone) in the root apical meristem was strongly increased in the p*RPS5A*::*TMO5*:GR x p*RPS5A*::*LHW*:GR (henceforth named double-GR or dGR) line compared to the control line upon a 24 h induction ([Figures 1](#fig1){ref-type="fig"}A--1D). In our experimental conditions, the dGR line resulted in much stronger induction of periclinal and radial divisions (PRD, [Figure S1](#mmc1){ref-type="supplementary-material"}A) compared to the single TMO5-GR or LHW-GR lines ([Figures S1](#mmc1){ref-type="supplementary-material"}B and S1C). Although the constitutive TMO5/LHW misexpression line \[[@bib4]\] resulted in significantly more divisions, the dGR line showed a very predictable increase in the number of cell divisions ([Figures S1](#mmc1){ref-type="supplementary-material"}B and S1C). Intriguingly, the first PRD already occurred after 4 h of DEX induction in the dGR line ([Figures 1](#fig1){ref-type="fig"}E--1H), while these divisions were not observed in control plants. These results suggest that all transcriptional changes required for PRD already occurred before this time. Also, prolonged induction of the dGR line resulted in cumulatively more PRD ([Figures 1](#fig1){ref-type="fig"}I and [S1](#mmc1){ref-type="supplementary-material"}D).Figure 1Simultaneous Induction of TMO5/LHW Results in Cell Proliferation(A--D) Confocal sections of untreated (A-B) and induced (C-D) dGR root meristems. Lines in A and C represent radial cross-sections of B and D, respectively.(E--H) Longitudinal optical sections of cortical cells in dGR root meristems treated with 10μM dexamethasone (DEX) for the indicated amount of time. Arrowheads mark induced PRD(I) Percentage of dGR plants showing additional periclinal and/or radial cell divisions (PRD) in time. Plants were scored to have additional PRD if one or more of these divisions were observed ectopically in longitudinal confocal sections.(J) Relative expression levels of genes in transcriptome data upon induction of the dGR line.(K--N) Expression of p*LOG4*::tandemTomato and pTCSn::ntandemTomato in dGR after mock treatment and after 24h DEX treatment. Asterisks indicate endodermis.Scale bars in (A)--(H) and (K)--(N): 25μm. See also [Figures S1](#mmc1){ref-type="supplementary-material"} and [S2](#mmc1){ref-type="supplementary-material"}, [Tables S1](#mmc2){ref-type="supplementary-material"} and [S2](#mmc3){ref-type="supplementary-material"}, and [Data S1](#mmc4){ref-type="supplementary-material"} and [S2](#mmc5){ref-type="supplementary-material"}.

Identification of DOF2.1 as Transcriptional Hub Downstream of TMO5/LHW {#sec1.2}
----------------------------------------------------------------------

We next interrogated the genome-wide transcriptional responses upon TMO5/LHW induction in a high-density time course experiment. After statistical analysis (fold change \> 2, q value \< 0.05, see [STAR Methods](#sec3){ref-type="sec"} for details), 237 genes were identified as significantly upregulated at one or more of the time points ([Table S1](#mmc2){ref-type="supplementary-material"}). We confirmed the regulation of a selection of 25 genes by qRT-PCR analysis, which included known TMO5/LHW target genes ([Table S2](#mmc3){ref-type="supplementary-material"}). In line with previous data \[[@bib3], [@bib6], [@bib11], [@bib12]\], the cytokinin (CK) biosynthesis genes, *LOG3* and *LOG4*, and other known targets, *SACL3* and *AT4G38650*, were quickly and strongly upregulated ([Figure 1](#fig1){ref-type="fig"}J and [Table S2](#mmc1){ref-type="supplementary-material"}). Intriguingly, following this first wave of direct target responses at 0.5--1 h of induction, a second wave of gene expression including A-type *ARABIDOPSIS RESPONSE REGULATORS* (*ARRs*) \[[@bib13], [@bib14]\] was observed between 1--3 h of DEX treatment ([Figure 1](#fig1){ref-type="fig"}J and [Table S2](#mmc1){ref-type="supplementary-material"}). Given that CK biosynthesis through *LOG3* and *LOG4* genes is activated at the 0.5--1 h time point, induction of downstream CK signaling reported by A-type *ARR* genes was expected, but not reported so far. Next, to understand the spatial aspects of dGR induction, reporters for CK biosynthesis (p*LOG4*::tdTomato) and CK signaling (pTCSn::ntdTomato) were analyzed. *LOG4* is expressed along the xylem axis and in protoxylem associated pericycle and endodermis, whereas TCSn is expressed in procambium, columella, epidermis, and root cap cells ([Figures 1](#fig1){ref-type="fig"}K and 1M). Upon induction, *LOG4* and TCSn were ectopically expressed outside of their normal domain in the root meristem ([Figures 1](#fig1){ref-type="fig"}L and 1N), confirming the activation of CK biosynthesis and CK signaling in all cell types in the root meristem upon induction of dGR.

As our high-resolution time-course dataset allowed the identification of consecutive waves of gene expression upon *TMO5/LHW* induction, we wanted to identify downstream transcriptional hubs using network inference analysis \[[@bib15]\]. To infer relationships and relative importance in the differentially expressed genes, we utilized the GENIST regulatory network inference algorithm \[[@bib15]\]. The application of GENIST resulted in 6 individual networks, corresponding to pairwise comparisons between the 0 h and all consecutive time points of the TMO5/LHW induction time course in which 0.5 h and 1 h were combined into one set (0 --0.5+1 h, 0--2h, 0--3 h, 0--4 h, 0--5 h, and 0--6 h) (see [STAR Methods](#sec3){ref-type="sec"} for details). Both *TMO5* and *LHW* were included in the network to provide a starting point for the transcriptional cascade. To illustrate the cascade of regulations through time, the networks were color coded for each time point ([Figure S2](#mmc1){ref-type="supplementary-material"}, see [Data S2](#mmc5){ref-type="supplementary-material"} for more information). A first wave of gene expression (red), starting from *TMO5*, includes its direct target genes. This is followed by a second wave (green), including CK response marked by *ARRs*. A third wave of gene expression (blue) includes several major nodes each controlling a high number of genes and thus marking the point where a large transcriptional change occurs. Notably, one of the most prominent nodes corresponded to *AT2G28510/DOF2.1*; a DOF-type TF previously suggested to be expressed in vascular tissues \[[@bib16], [@bib17]\]. To investigate this regulatory network in more detail and highlight significant regulations, we generated a subnetwork focusing only on *TMO5*, *ARR12*, *DOF2.1*, and their predicted direct target genes (see [Data S2](#mmc5){ref-type="supplementary-material"} for more information). First, this network correctly predicts *TMO5* to regulate all known target genes, including *SACL3* (represented as *uORF34* and *uORF35*), *BUD2*, *LOG3*, and *LOG4*, thus confirming earlier results \[[@bib3], [@bib6], [@bib11], [@bib12]\]. Second, *DOF2.1* is predicted to act downstream of *ARR12*, not *TMO5*, suggesting that this gene might not be a direct target gene but is likely regulated by CK signaling pathway, which is reported to be activated by TMO5/LHW (see [Data S2](#mmc5){ref-type="supplementary-material"} for more information).

*DOF2.1* Expression Is Controlled by TMO5/LHW-Dependent CK {#sec1.3}
----------------------------------------------------------

To investigate the role of *DOF2.1* as a downstream target of TMO5/LHW, we first generated a transcriptional p*DOF2.1*::GUS-GFP reporter line. During embryogenesis, *DOF2.1* is first expressed in the upper tier in heart stage ([Figures 2](#fig2){ref-type="fig"}A--2C) and shows expression in the embryonic root at torpedo stage ([Figure 2](#fig2){ref-type="fig"}C). Post-embryonically, *DOF2.1* shows weak expression in the aerial tissues and high expression throughout the root ([Figures S3](#mmc1){ref-type="supplementary-material"}A and S3B). Specifically, in the root apical meristem, *DOF2.1* is strongly expressed in xylem pole pericycle cells, in specific neighboring procambium cells, and in the flanking endodermal cells ([Figures 2](#fig2){ref-type="fig"}D and 2E), suggesting that the bilateral symmetry of the root might extend beyond the central vascular cylinder \[[@bib18]\]. Given that some DOF-type TFs have been reported to be mobile \[[@bib19]\], we next investigated if the 31.8 kDa DOF2.1 protein might be a mobile factor. Protein accumulation of a translational p*DOF2.1*::*DOF2.1*:YFP fusion recapitulated the expression pattern of the transcriptional reporter line ([Figures 2](#fig2){ref-type="fig"}F and 2G), suggesting that DOF2.1 is not moving outside of its domain of expression. We next examined *DOF2.1* expression upon TMO5/LHW induction and observed that *DOF2.1* expression extended outside its normal domain and into the ground tissue cells neighboring the phloem poles ([Figures 2](#fig2){ref-type="fig"}H and 2I). Notably, no expression of *DOF2.1*, both prior and upon induction of TMO5/LHW, was observed in xylem, centrally located procambium or the phloem lineage cells. However, the *RPS5A* promoter is expressed in this zone ([Figure 2](#fig2){ref-type="fig"}J), and CK signaling (but not auxin signaling) is activated in these cells by TMO5/LHW \[[@bib3], [@bib6]\] as visualized by a newly generated dual color, single locus auxin/CK-signaling reporter line (pTCSn::ntdTomato - pDR5revV2::n3GFP) ([Figures 2](#fig2){ref-type="fig"}K and 2L). These results suggest an active suppression of *DOF2.1* expression in the center of the root vasculature. To provide additional evidence that *DOF2.1* acts downstream of TMO5/LHW, we first analyzed its relative expression levels in *lhw* single and *tmo5 tmo5-like1* double mutant backgrounds by qRT-PCR and found that these were reduced ([Figure S3](#mmc1){ref-type="supplementary-material"}F). Because these mutants have a reduced vascular bundle with only one xylem pole and *DOF2.1* is mostly expressed in this area, it could well be that the observed result is due to the altered anatomy of these mutants. Hence, we introduced the p*DOF2.1*::GUS-GFP reporter line in the *tmo5 tmo5-like1* double mutant background to observe changes in the tissue specific expression levels. Expression level was reduced in this mutant backgrounds supporting that *DOF2.1* expression depends on functional TMO5/LHW ([Figures 2](#fig2){ref-type="fig"}M and 2N).Figure 2DOF2.1 Expression in Xylem-Pole-Associated Cells(A--C) Expression of p*DOF2.1*::GFP-GUS during embryogenesis. Arrows indicate expression in the embryonic root.(D--I) Optical sections of the primary root meristems of p*DOF2.1*::GUS-GFP (D and E), p*DOF2.1::DOF2.1*:YFP (F and G) and p*DOF2.1*::GFP-GUS in dGR upon 24h DEX treatment (H and I).(J) Optical cross section of p*RPS5A*::nGFP-GUS in the root meristem.(K and L) TCSn::ntdTomato-DR5revV2::n3GFP expression in dGR after 24h DEX treatment. The line in (K) represents the optical cross section shown in (L).(M and N) p*DOF2.1*::GUS-GFP expression in Col-0 and *tmo5 tmo5like1* double mutant background.(O) Relative expression levels of *DOF2.1* upon treatment with 10 μM Benzyl Adenine (BA) for 0, 1, 2, 6, and 24 h as determined by qRT-PCR analysis.(P) Relative expression levels of *DOF2.1* upon treatment with 10 μM BA in Col-0 and *wol* mutant backgrounds.In all qRT-PCR experiments, data are represented as mean ± SEM and asterisks indicate significance (^∗∗^p \< 0.001; n.s.: not significant) as determined by two-sided t-tests. In all confocal images, asterisks indicate endodermis and crosses indicate xylem cells; scale bars, 25 μm. See also [Figures S1](#mmc1){ref-type="supplementary-material"}, [S2](#mmc1){ref-type="supplementary-material"}, [S3](#mmc1){ref-type="supplementary-material"} and [Data S1](#mmc4){ref-type="supplementary-material"}.

Next, given that *DOF2.1* is induced later than *LOG4* upon TMO5/LHW induction (3-4h for *DOF2.1* compared to 0.5-1h for *LOG4*, see [Table S1](#mmc2){ref-type="supplementary-material"}**-2**); that the *DOF2.1* expression pattern is very similar to that of *LOG3* and *LOG4* \[[@bib3]\] and that our network analysis predicts *DOF2.1* to act downstream of ARR12 ([Table S2](#mmc3){ref-type="supplementary-material"}), we questioned if *DOF2.1* could act downstream of the TMO5/LHW-dependent CK biosynthesis. Indeed, *DOF2.1* transcript levels were quickly induced in root meristems by exogenous CK treatments in a qRT-PCR experiment ([Figure 2](#fig2){ref-type="fig"}O) and in seedlings \[[@bib20], [@bib21]\]; but this induction was abolished in a *wooden leg* (*wol*) mutant background ([Figure 2](#fig2){ref-type="fig"}P). These results suggest that *DOF2.1* is transcriptionally controlled by CK. A CK-dependent regulation of *DOF2.1* expression levels was further supported by several recent reports showing direct binding of the well-known B-type ARRs executors of CK signaling ARR1, ARR10, and ARR12 to the *DOF2.1* promoter region \[[@bib21], [@bib22]\]. Thus, although we cannot exclude additional CK-independent regulation of *DOF2.1* at the moment, collectively, these results suggest that *DOF2.1* acts downstream of the TMO5/LHW-dependent CK biosynthesis.

DOF2.1 and Its Close Homologs Control Vascular Cell Proliferation {#sec1.4}
-----------------------------------------------------------------

As the inferred network analysis predicts that *DOF2.1* would act as a major downstream transcriptional hub, we next questioned whether this CK-inducible DOF-type TF is indeed involved in controlling vascular cell proliferation. Given that a single *dof2.1* loss-of-function did not result in obvious phenotypes ([Figures 3](#fig3){ref-type="fig"}A--3C) and the possible redundancy in the large DOF-type TF family, we quantified the relative expression levels of the two closest homologs, namely *TMO6* and *DOF6* ([Figure S3](#mmc1){ref-type="supplementary-material"}E), in the *dof2.1* line. The relative expression levels of the latter were upregulated ([Figure 3](#fig3){ref-type="fig"}D), hinting toward compensatory regulation. Hence, we generated a triple mutant of *DOF2.1*, *DOF6*, and *TMO6* to overcome the redundancy within this subclade of the DOF transcription factor family using the CRISPR/Cas9 system ([Figure S4](#mmc1){ref-type="supplementary-material"}). Using confocal cross sections to quantify the number of cell files in the root meristem, the *dof2.1-2 tmo6-1 dof6-2* triple mutant showed a significant reduction in the total number of cell files and in the number of vascular cell files when compared to Col-0 ([Figures 3](#fig3){ref-type="fig"}C and 3E), suggesting that these closely related DOF-type TFs act in a redundant manner to control vascular proliferation. To further examine the redundancy of these factors, we analyzed the expression patterns of p*TMO6* and p*DOF6* and found that they are only partly overlapping but mostly distinct from the *DOF2.1* expression domain. *DOF6* shows sieve element specific expression, and the *TMO6* reporter line is more broadly expressed in phloem-associated procambium cells ([Figures 3](#fig3){ref-type="fig"}F--3I). Intriguingly, *TMO6* and *DOF6* are also CK inducible ([Figure 3](#fig3){ref-type="fig"}J) in a wild-type, but not a *wol*, background ([Figure 3](#fig3){ref-type="fig"}K) and are mildly regulated in the transcriptome data-set ([Figure S3](#mmc1){ref-type="supplementary-material"}J). To investigate the potential that these factors regulate specific divisions in the procambium based on their expression domains, we quantified the number of procambium cells in single-, double-, and triple-mutant combinations using optical cross sections. Additionally, we quantified both procambium cells associated with the protoxylem pole next to the pericycle (where DOF2.1 is mostly expressed: outer procambium cells - OPC) as well as those associated with the phloem pole toward the inside of the vascular bundle (showing no *DOF2.1* expression: inner procambium cells - IPC) ([Figure 3](#fig3){ref-type="fig"}L). The number of OPC cell files was significantly reduced in *dof2.1-1* ([Figure 3](#fig3){ref-type="fig"}M). Although a second *dof2.1-2* allele did not show a reduction by itself, it did significantly enhance the effect of the *tmo6-1 dof6-2* double mutant, suggesting that both alleles are functional. On the contrary, neither of the *dof2.1* alleles had a significant effect on the number of IPC cells ([Figure S3](#mmc1){ref-type="supplementary-material"}J), while multiple *dof6 tmo6* double mutant combinations significantly reduced IPC numbers ([Figure S3](#mmc1){ref-type="supplementary-material"}J). Thus, these results suggest that DOF2.1 specifically controls the number of OPC divisions, while TMO6 and DOF6 show the strongest effect toward the IPC cell numbers. Intriguingly, the *dof2.1-2 tmo6-1 dof6-2* triple mutant also showed a mild reduction in the number of vascular cell files in mature embryos ([Figure S3](#mmc1){ref-type="supplementary-material"}H), suggesting that these DOF-type TF might act from embryogenesis onward. Taken together, multiple DOF-type TFs control cell divisions in specific sets of procambium cells during early vascular development.Figure 3DOF2.1 Controls Specific Procambium Divisions(A, B, and E) Optical sections of root meristems of Col-0, *dof2.*1-1 and *dof2.1-2 tmo6-1 dof6-2*, respectively.(C) Quantification of the cell file number of *dof2.1* (left panel) and *dof2.1-2 tmo6-1 dof6-*2 (triple mutant) (right panel) with respective controls.(D) Relative expression levels of *DOF2.1*, *DOF6* and *TMO6* in Col-0 and *dof2.1-1* as determined by qRT-PCR analysis.(F--I) p*DOF6*::erVENUS and p*TMO6*::erRFP expression in root apical meristems. Location of cross sections in G and I are indicates with lines in F and H respectively.(J) Relative expression levels of *DOF6* and *TMO6* upon treatment with 10 μM BA for 0, 1, 2, 6 and 24h as determined by qRT-PCR analysis.(K) Relative expression levels of *DOF6* and *TMO6* upon 2 h treatment with 10 μM BA in Col-0 and *wol* mutant backgrounds.(L) Schematic overview of different cell types in the vascular bundle, indicating OPC and IPC cells.(M) Quantification of OPC cell numbers in the mutant backgrounds indicated with the respective controls.In all qRT-PCR experiments and cell number quantifications, data are represented as mean ± SEM and asterisks indicate significance (^∗∗^p \< 0.001; ^∗^p \< 0.05; n.s.: not significant) as determined by two-sided t-tests; small case letters in M indicate significantly different groups as determined using a one-way ANOVA with post hoc Tukey HSD testing and sample numbers are indicated above the x axis. In all confocal images, asterisks indicate endodermis and crosses indicate xylem cells; scale bars, 25 μm. See also [Figure S3](#mmc1){ref-type="supplementary-material"} and [S4](#mmc1){ref-type="supplementary-material"} and [Data S1](#mmc4){ref-type="supplementary-material"}.

Next, to investigate whether DOF2.1 is sufficient to induce PRD, we generated an inducible p*RPS5A*::*DOF2.1*:*GR* misexpression line. Upon induction, this line showed an increased number of cell files for each cell type in the root meristem when compared to Col-0 ([Figures 4](#fig4){ref-type="fig"}A--4D). To gain insights into the temporal dynamics, we next analyzed this induction of PRD in a time series experiment. Similar to what we observed after TMO5/LHW induction ([Figures 1](#fig1){ref-type="fig"}E--1H), p*RPS5A*::*DOF2.1*:*GR* showed the first radial divisions after only 6 h DEX induction ([Figures 4](#fig4){ref-type="fig"}E--4G and [S3](#mmc1){ref-type="supplementary-material"}I). Although a similar effect was observed upon inducing *TMO5/LHW* or *DOF2.1*, the former involves the activation of CK biosynthesis. As such, the effects of constitutive TMO5/LHW overexpression are not limited to induction of PRD but also include other CK-related phenotypes such as inhibition of protoxylem cell differentiation \[[@bib3], [@bib6]\]. Following the logic that DOF2.1 acts downstream of CK signaling, plants with elevated *DOF2.1* levels exhibit normally differentiated protoxylem cells ([Figures 4](#fig4){ref-type="fig"}H--4J), suggesting that DOF2.1 specifically controls vascular proliferation without causing other pleiotropic CK-related effects. Nevertheless, likely due to divisions of the young xylem cells, constitutive misexpression of *DOF2.1* occasionally showed the formation of additional protoxylem cell files with normal differentiation ([Figures S3](#mmc1){ref-type="supplementary-material"}C and S3D). Next, we introduced the p*RPS5A*::*DOF2.1*:GR line into the *tmo5 tmo5-like1* double and *lhw* single mutants \[[@bib4], [@bib23]\]. Induction of *DOF2.1* led to an increase in the total number of cell files of the root meristem in both *tmo5 tmo5-like1* double and *lhw* single mutant backgrounds ([Figure 4](#fig4){ref-type="fig"}K). Thus, these results suggest that DOF2.1 acts as a transcriptional hub downstream of TMO5/LHW and is both required and sufficient to controlling vascular cell proliferation.Figure 4DOF2.1 Is Sufficient to Trigger PRD(A--D) Optical sections of Col-0 and p*RPS5A*::DOF2.1. Lines in A and C indicate position of cross sections in B and D respectively.(E--G) Longitudinal sections of the epidermis in p*RPS5A*::*DOF2.1*:GR after DEX induction for the indicated time.(H--J) DIC images of the differentiated vasculature of Col-0, dGR and p*RPS5A*::*DOF2.1*:GR in five-day-old seedlings.(K) Quantification of the cell file number in *lhw* and *tmo5 tmo5like1* mutant backgrounds harboring the p*RPS5A*::*DOF2.1*:GR rescue construct with (DEX) and without (MS) treatment with 10μM DEX.In all cell number quantifications, asterisks indicate significance (^∗∗^p \< 0.001) as determined by two-sided t-tests and sample numbers are indicated above the x axis. In all confocal images, asterisks indicate endodermis; scale bars, (A)--(D) 25 μm, (E)--(G) 10 μm. See also [Figure S3](#mmc1){ref-type="supplementary-material"} and [Data S1](#mmc4){ref-type="supplementary-material"}.

Discussion {#sec2}
==========

Although over 200 genes were identified as being transcriptionally upregulated upon simultaneous induction of TMO5 and LHW, only a few were suggested to act as major transcriptional hubs in the inferred network analysis. We focused our attention to one of these, *DOF2.1*, previously reported to be expressed in vascular tissues \[[@bib17]\]. We showed that *DOF2.1* acts downstream of the TMO5/LHW-dependent cytokinin response and, together with its closest homologs, controls vascular proliferation. Several other DOF-type transcription factors have been reported to be expressed in vascular tissues \[[@bib17], [@bib19]\], suggesting a more prominent role for this family of transcription factors in regulating vascular development. For example, DOF5.6/HCA2 was reported to be involved in controlling divisions in the interfascicular cambium although no phenotypes were observed in root tissues \[[@bib24]\]. Given that the observed reduction in cell file number is weaker in the triple *dof2.1-2 tmo6-1 dof6-2* mutant compared to the reduction observed in higher order mutants of the *tmo5* of *lhw* subclades \[[@bib4]\], it is likely that more DOF family members are involved in controlling this process. However, *DOF2.1* is the only DOF-type transcription factor we clearly identified as TMO5/LHW target, suggesting that other members of this large transcription factor family are likely to be under control of different signals or might act during different stages of development.

Here, we showed that at least three DOF-type transcription factors DOF2.1, TMO6, and DOF6 control specific subsets of procambium cell divisions leading to vascular proliferation in the root meristem, with DOF2.1 specifically controlling OPC divisions, while TMO6 and DOF6 have the strongest effect on IPC cell numbers. This differential response suggests that the procambium is not a homogeneous pool of cells. Indeed, distinct zones might exist along the longitudinal and radial axis of procambial tissue, showing differential properties in cell division potential and thus also regulatory mechanisms. In this aspect, it would be interesting to investigate the contribution of these cell populations to secondary growth when procambium cells are reactivated.

*DOF2.1* is specifically expressed in cells surrounding the xylem poles but remains absent from the central region of the vascular bundle even when ectopically expressed in this domain. This observation suggests that *DOF2.1* expression levels might be actively repressed in this zone. Intriguingly, CLASS III HOMEODOMAIN LEUCINE ZIPPER (HD-ZIPIII) transcription factors are expressed in this central region and have been shown to act as negative regulators of cell proliferation \[[@bib25]\]. Besides the fact that several DOF factors have been identified as binding to the promoter regions of HD-ZIPIII genes \[[@bib26]\], it would be interesting to investigate if these factors might at the same time act as negative regulators of DOF-type TF expression.

STAR★Methods {#sec3}
============

Key Resources Table {#sec3.1}
-------------------

REAGENT or RESOURCESOURCEIDENTIFIER**Bacterial and Virus Strains***Agrobacterium tumefaciens* C58 PMP90N/AN/A*Escherichia coli* DH5αThermo-FisherCat\# 18265017**Chemicals, Peptides, and Recombinant Proteins**5-bromo-4-chloro-3-indolyl β-D-glucopyranoside-sodium salt(X-Glc)X-Gluc DirectN/A6-BenzylaminopurineDuchefa BiochemieCat\# B0904ATPNew England BiolabsCat\# P0765BbsINew England BiolabsCat\# R3539BsaINew England BiolabsCat\# R0535Calcofluor WhiteSigma-AldrichCat\# 18909CarbenicillinDuchefa BiochemieCat\# C0109DexamethasoneSigma-AldrichCat\# D4902Dimethyl sulfoxideSigma-AldrichCat\# 472301Dimethylformamide (DMF)Sigma-AldrichCat\# D4092GlycerolSigma-AldrichCat\# G6279KanamycinDuchefa BiochemieCat\# K0126Lactic acidArcos OrganicsCat\# 189870010MESDuchefa BiochemieCat\# M01503MS-saltDuchefa BiochemieCat\# M0221ParaformaldehydeSigma-AldrichCat\# 158127Potassium Ferricyanide (K3Fe(CN)6)Sigma-AldrichCat\# 702587Potassium Ferrocyanide (K4Fe(CN)6)Sigma-AldrichCat\# P9837Propidium IodideSigma-AldrichCat\# P4170Q5 High-Fidelity DNA polymeraseNew England BiolabsCat\# M0491RifampicinDuchefa BiochemieCat\# R0146SCRI Renaissance Stain 2200Renaissance ChemicalsN/ASilwetLehle SeedsCat\# VIS-30Sodium deoxycholateSigma-AldrichCat\# 30970Sodium metabisulphiteMerckCat\# 106528SpectinomycinDuchefa BiochemieCat\# S0188T4-DNA LigaseNew England BiolabsCat\# M0202Triton X-100MerckCat\# 11869UreaUSBCat\# 75826XylitolSigma-AldrichCat\# X3375**Critical Commercial Assays**GeneJET Plasmid Miniprep KitThermo-FisherCat\# K0503iScript cDNASynthesis KitBio-RadCat\# 1708890LightCycler 480 SYBR Green I MasterRoche DiagnositicsCat\# 50-720-3180MultiSite Gateway™ Pro PlusThermo-FisherCat\# 12537100NEB Golden Gate Assembly KitNew England BiolabsCat\# E1601RNeasy Plus Mini KitQIAGENCat\# 74136**Deposited Data**Transcriptomics datafilesGene Expression OmnibusGEO: [GSE116858](ncbi-geo:GSE116858){#intref0010}**Experimental Models: Organisms/Strains***Arabidopsis*: Col-0Nottingham *Arabidopsis* Stock CentreN/A*Arabidopsis*: *dof2.1-1*MPI for Plant Breeding Research; Cologne, Germany \[[@bib27]\]GK-668G12*Arabidopsis*: *dof2.1-2*This paperN/A*Arabidopsis*: *dof2.1-2 tmo6-1 dof6-2*This paperN/A*Arabidopsis*: *lhw*\[[@bib4]\]N/A*Arabidopsis*: p*DOF2.1*::DOF2.1:sYFPThis paperN/A*Arabidopsis*: p*DOF2.1*::GFP/GUSThis paperN/A*Arabidopsis*: p*DOF6*::erVENUSThis paperN/A*Arabidopsis*: p*LOG4*::tdTomatoThis paperN/A*Arabidopsis*: p*RPS5A*::DOF2.1This paperN/A*Arabidopsis*: p*RPS5A*::DOF2.1-GRThis paperN/A*Arabidopsis*: p*RPS5A*::LHW:GRThis paperN/A*Arabidopsis*: p*RPS5A*::nGFP-GUSThis paperN/A*Arabidopsis*: p*RPS5A*::TMO5:GR\[[@bib4]\]N/A*Arabidopsis*: p*RPS5A*::TMO5:GR x p*RPS5A*::LHW:GRThis paperN/A*Arabidopsis*: pTCSn::ntdTomato - pDR5revV2::n3GFPThis paperN/A*Arabidopsis*: p*TMO6*::erRFPThis paperN/A*Arabidopsis*: *tmo5 tmo5-like1*\[[@bib4]\]N/A*Arabidopsis*: *tmo6-1 dof6-2*This paperN/A*Arabidopsis*: *tmo6-4 dof6-1*This paperN/A*Arabidopsis*: *wol*\[[@bib28]\]N/A*Arabidopsis*: *dof6-1*Nottingham *Arabidopsis* Stock CentreWiscsDsLox351c08**Oligonucleotides**See table S1N/AN/A**Recombinant DNA**pBGWFS7VIB-Ugent Center For Plant Systems Biology<https://gateway.psb.ugent.be/>pBGWFS7 p*DOF2.1*::GFP/GUSThis paperN/Ap*DOF2.1*::DOF2.1:sYFPThis paperN/ApDONR221Thermo-FisherN/ApDONRP2RP3Thermo-FisherN/ApDONRP4P1RThermo-FisherN/ApDONRP4-P1R *pRPS5A*This paperN/ApFASTRK_AtCas9_AG\[[@bib29]\]N/ApGG-A-ATU6PTA-B\[[@bib29]\]N/ApGG-B-ATU6PTA-C\[[@bib29]\]N/ApGG-C-ATU6PTA-D\[[@bib29]\]N/ApGG-D-ATU6PTA-E\[[@bib29]\]N/ApGG-D-ATU6PTA-E\[[@bib29]\]N/ApGIIM/LIC_SwaI-ntdTomato - pDR5revV2-n3GFP\[[@bib30]\]N/ApHm34GWVIB- UGent Center For Plant Systems Biology<https://gateway.psb.ugent.be/>pHm34GW p*DOF6*::erVENUSThis paperN/ApHm34GW p*TMO6*::erRFPThis paperN/ApHm42GWVIB-UGent Center For Plant Systems Biology<https://gateway.psb.ugent.be/>pHm42GW p*RPS5A*::DOF2.1This paperN/ApHm43GWVIB-UGENT Center For Plant Systems Biology<https://gateway.psb.ugent.be/>pHm43GW p*RPS5A*::DOF2.1-GRThis paperN/ApMK7S-NFm14GW,0 p*RPS5A*VIB- UGent Center For Plant Systems Biology<https://gateway.psb.ugent.be/>p*RPS5A*::LHW:GRThis paperN/Ap*RPS5A*::nGFP-GUSThis paperN/ApTCSn::ntdTomato\[[@bib31]\]N/ApTCSn::ntdTomato - pDR5revV2::n3GFPThis paperN/A**Software and Algorithms**BoxPlotRN/A<http://shiny.chemgrid.org/boxplotr/>; RRID:[SCR_015629](rridsoftware:SCR_015629){#intref0045}CRISPR-P\[[@bib32]\]<http://crispr.hzau.edu.cn/CRISPR/>CytoscapeN/A<https://cytoscape.org>; RRID:[SCR_003032](rridsoftware:SCR_003032){#intref0060}Microsoft ExcelMicrosoftRRID:[SCR_016137](rridsoftware:SCR_016137){#intref0065}GENIST\[[@bib15]\]<https://github.com/madeluis/GENIST/commits/master>ImageJN/A<https://imagej.nih.gov/ij/>; RRID:[SCR_003070](rridsoftware:SCR_003070){#intref0080}Leica Application Suite XLeica Microsystems<https://www.leica-microsystems.com>; RRID:[SCR_013673](rridsoftware:SCR_013673){#intref0090}qBASE+Biogazelle<https://www.qbaseplus.com/>; RRID:[SCR_003370](rridsoftware:SCR_003370){#intref0100}**Other**Leica SP2 confocal microscopeLeica MicrosystemsN/ALeica SP8 confocal microscopeLeica MicrosystemsN/ALightCycler 480Roche Life SciencesN/AOlympus BX53Olympus LifesciencesN/A

Contact for Reagent and Resource Sharing {#sec3.2}
----------------------------------------

Further information and requests for resources and reagents should be directed to and will be fulfilled by Bert De Rybel (<beryb@psb.vib-ugent.be>).

Experimental Model and Subject Details {#sec3.3}
--------------------------------------

*Arabidopsis thaliana* (L.) Heynh. background lines Columbia-0 (Col-0), were used for experimentation, with mutants and transgenic lines in these backgrounds as detailed in the Key Resources Table. *Arabidopsis* seedlings were cultivated at 22°C under continuous light conditions.

Method Details {#sec3.4}
--------------

### Plant material and growth conditions {#sec3.4.1}

All seeds were surface sterilized, sown on solid ½ MS plates without sucrose, and stratified for 24h at 4°C two days before they were grown at 22°C in continuous light conditions. Ten day old seedlings were transferred to soil and grown in green house conditions. Dexamethasone (DEX) treatment was performed by either germinating seeds on 10μM DEX-supplemented medium or by transferring plants from ½ MS to 10μM DEX supplemented medium and continuing growth for the indicated time. Benzyl Adenine (BA) treatment was performed by transferring plants from ½ MS to 10μM BA supplemented medium and continuing growth for the indicated time. Both BA and DEX were dissolved in dimethyl sulfoxide. The *dof2.1-1* T-DNA mutant used (GK-668G12) was generated in the context of the GABI-Kat program and provided by Bernd Weisshaar (MPI for Plant Breeding Research; Cologne, Germany) \[[@bib27]\]. The *Arabidopsis thaliana* (L.) Heynh. Col-0 ecotype served as wild-type control in all experiments. The AGI identifiers for the genes used in this study were as follows: *DOF2.1*: *AT2G28510*, *TMO6*: *AT5G60200*, *DOF6*: *AT3G45610*, *TMO5*: *AT3G25710*, *LHW*: *AT2G27230*, *LOG3*: *AT2G37210*, *LOG4*: *AT3G53450*, *ARR1*: *AT3G16857*, *ARR10*: *AT4G31920*, *ARR12*: *AT2G25180*, *SACL3*: *AT1G29950*, *ACL5*: *AT5G19530*.

### Cloning and plant transformation {#sec3.4.2}

The p*RPS5A*::*TMO5*:GR x p*RPS5A*::*LHW*:GR or dGR line was generated by first fusing the LHW coding sequence to the mammalian glucocorticoid receptor (GR) and driving this from the strong meristematic *RPS5A* promoter \[[@bib10]\] using LIC cloning \[[@bib33], [@bib34]\]. This p*RPS5A*::LHW:GR line was next crossed into the existing p*RPS5A*::TMO5:GR line \[[@bib4]\] to obtain the dGR line. The pTCSn::ntdTomato - pDR5revV2::n3GFP \[[@bib30], [@bib31]\] construct was generated by using PCR to generate the TCSn promoter fragment with appropriate LIC adapters. This was inserted into the pGIIM/LIC_SwaI-ntdTomato - pDR5revV2-n3GFP destination vector \[[@bib30]\] using the LIC cloning system. Other vectors were generated using Gateway Technology (Thermo-Fisher). p*RPS5A*::DOF2.1 was generated by cloning the DOF2.1 genomic sequence in the pDONR221 entry vector and subsequently recombining it with the p*RPS5A* pDONRP4P1R in the pHm42GW destination vector. p*RPS5A*::DOF2.1-GR was generated by cloning DOF2.1 genomic sequence without stop in the pDONR221 entry vector and subsequently recombining it with the p*RPS5A* pDONRP4P1R and GR pDONRP2RP3 in a pHm43GW destination vector. The DOF2.1 promoter was obtained by amplifying the 3711bp upstream region of the transcriptional start and cloning this into the pDONRP41R entry vector. p*DOF2.1*::GFP/GUS was generated by cloning the *DOF2.1* promoter region in pBGWFS7 destination vector using Gateway cloning. The TMO6 and DOF transcriptional fusions were generated by cloning the promoter regions into the pDONRP41R entry vector and combining these with erRFP and erVENUS respectively into the pHm34GW destination vector. p*DOF2.1*::DOF2.1:sYFP was obtained by cloning the p*DOF2.1*, DOF2.1 genomic sequence minus stop, and sYFP entry clones in the pHm43GW destination vector using Gateway cloning. p*RPS5A*::nGFP-GUS was generated by amplifying the p*RPS5A* promoter sequence \[[@bib10]\] and cloning this into the pDONRP4P1R and subsequently cloning this into the pMK7S-NFm14GW,0 destination vector. All constructs were verified by Sanger sequencing and were transformed into Col-0 using simplified floral dipping. All primer sequences used for cloning and sequencing can be found in [Data S1](#mmc4){ref-type="supplementary-material"}.

### CRISPR/CAS9 mutant generation {#sec3.4.3}

Two guide RNAs (gRNAs) were designed per gene using the CRISPR-P tool \[[@bib32]\]. Cloning of gRNA vectors was performed essentially as previously described \[[@bib29]\]. Briefly, gRNA oligos were appended with the corresponding overlaps (FW: 5′-ATTG REV: 5′-AAAC) to enable annealed-oligo cloning. Primers used for cloning and sequencing can be found in [Data S1](#mmc4){ref-type="supplementary-material"}. Oligos were annealed and ligated into six Golden Gate gRNA entry modules using standard DNA ligation and sequenced verified. The gRNA entry plasmids were cloned into the pFASTRK_AtCas9_AG destination vector (<https://gateway.psb.ugent.be>) using Golden Gate assembly. Expression vectors were sequenced to verify successful insertion of the gRNAs. Positive expression vectors were transformed into *Agrobacterium tumefaciens* C58 PMP90. Plants were transformed with Agrobacterium cultures using floral dip. Transformed events were selected based on red seed fluorescence and sown on soil. Knockout mutations in the target genes were confirmed in the T1 generation by PCR amplification and Sanger sequencing followed by TIDE analysis \[[@bib35]\]. T2 seeds lacking red seed fluorescence (Cas9 null segregants) were sown on soil and plants again screened for the desired editing events. Cas9-free, homozygous knockout plants were selected and seeds harvested. Desired editing events were confirmed in T3 generation by Sanger sequencing. T3 seeds were used for all experiments.

### Plant imaging and image processing {#sec3.4.4}

For differential interference contract (DIC) microscopy, samples were mounted in a solution of 20% glycerol 60% lactic acid and imaged using an Olympus BX53 microscope equipped with DIC optics. Expression of pDOF2.1::GFP-GUS for DIC analysis was visualized using GUS staining as described in \[[@bib36]\].Cell wall staining for optical cross sections was done using modified Pseudo Schiff -- Propidium Iodine (mPS-PI) \[[@bib37]\]. Marker lines were cleared using the ClearSee protocol \[[@bib38]\] including a cell wall staining with 0.1% Calcofluor White \[[@bib39]\]. Confocal microscopy was performed on Leica SP8 (40X) and Leica SP2 (63X) (all water corrected objective lenses with NA 1.2) confocal microscopes. Calcofluor White, GFP, sYFP, tandemTomato (tdT) and propidium iodide (PI) samples were imaged at an excitation of 405nm, 488nm, 514nm, 561nm and 514nm respectively. Calcofluor White, GFP, tdT and PI were visualized at an emission of 425-475 nm, 500-535nm, 520-550nm, 580-630nm and 600-700nm respectively. Embryos were fixed and stained using Renaissance \[[@bib40]\]. Embryos were popped out of the ovules and R2200 and GFP were visualized by excitation at 405 and 488 nm and detection between 430-470 nm and 500-535 nm, respectively

### qRT-PCR {#sec3.4.5}

RNA was extracted with the RNeasy kit (QIAGEN). Poly(dT) cDNA was prepared from 1 mg of total RNA with an iScript cDNA Synthesis Kit (Bio-Rad) and analyzed on a LightCycler480 apparatus (Roche) with SYBR GREEN I Master kit (Roche) according to the manufacturer's instructions. Primer pairs were designed with the Universal Probe Library Assay Design Center (Roche). Experiments were repeated in triplicate, each with three technical replicates. Data was analyzed using qBase+ software package (Biogazelle). Expression levels were normalized to those of EEF1α4 and CDKA1;1. All primers used for qRT-PCR analysis can be found in [Data S1](#mmc4){ref-type="supplementary-material"}

### Whole genome transcriptome analysis {#sec3.4.6}

pRPS5A::TMO5:GR x pRPS5A::LHW:GR (dGR) and Col-0 seeds were bleach sterilized and stratified for 24h at 4°C. Seeds were sown on ½ MS plates and grown for 5 days in a growth room at 22°C. 5-day old plants of both Col-0 and dGR were transferred to ½ MS plates containing 10 μM DEX and mock-plates and were sampled at the following time points: 0h, 0.5h, 1h, 2h, 3h, 4h, 5h and 6h. 300 individual root tips were sampled per sample and three biological repeats per time point were used. Root tips were harvested directly into liquid nitrogen, RNA was extracted using the RNeasy kit (QIAGEN). Total RNA (100 ng) was labeled using an Ambion WT expression kit (Life Technologies) and hybridized to *Arabidopsis* Gene 1.0 ST arrays (Affymetrix), that probes the expression of 27,827 unique genes. Sample labeling; hybridization to chips and image scanning was performed according manufacturer's instructions. Microarray analysis was performed using MADMAX pipeline for statistical analysis of microarray data \[[@bib41]\]. Expression values were calculated using robust multichip average (RMA) method, which includes quantile normalization \[[@bib42], [@bib43]\]. Probe sets on the array were redefined using current genome information \[[@bib44]\]. In this study, probes were reorganized on the basis of the gene definitions as available in the TAIR10 database.

### Network inference {#sec3.4.7}

To infer a gene regulatory network (GRN) and predict the causal relationships of genes regulated by TMO5 and LHW, differentially expressed genes (DEGs) were identified using q \< 0.05 & fold change \> 2 as our selection criteria, when performing pairwise comparisons between hours 0-0.5, 0-1, 0-2, 0-3, 0-4, 0-5, and 0-6 of the TMO5/LHW induction time course. This resulted in the identification of 237 genes differentially expressed at 0.5, 1, 2, 3, 4, 5, and 6 hours after TMO5/LHW induction, which contained 22 transcription factors ([Table S2](#mmc3){ref-type="supplementary-material"}). To preserve the temporal cascade of regulations, the network was inferred as individual GRNs containing the DEGs at each time point, as opposed to predicting a GRN containing the 237 DEGs together. Specifically, because we assume that regulation between genes can occur, not only during concurrent time points, but also between consecutive time points, the DEGs from consecutive time points were grouped (0.5-1, 1-2, 2-3, 3-4, 4-5, 5-6 hours), and GRNs from each of the 6 resulting lists of genes were inferred. The GRN inference on each of the 6 sets of DEGs was performed by applying a dynamic Bayesian network (DBN)-based inference algorithm, GENIST \[[@bib15]\]. Since GENIST offers the possibility of clustering genes based on their co-expression prior the inference step to improve the performance of the algorithm, GENIST was ran using a previously published TMO5-GR dataset (TMO5 induced for short time points and a cell sorted set) \[[@bib3]\] for the clustering step. Details about the application of GENIST to each of the 6 sets of genes are provided below.

#### 1. Gene selection {#sec3.4.7.1}

The genes differentially expressed at each time point after induction of TMO5/LHW, $\text{g}_{\text{t}},\text{~for~t} \in \left\{ {0.5,\ 1,\ 2,\ 3,\ 4,\ 5,\ 6\ } \right\}$ hours were selected. Then, the DEG from every two consecutive time points, $\text{g}_{\text{t}}\text{~and~g}_{\text{t} + 1}$, were combined in sets $S\tau,for\ \tau \in \left\{ 0.5\& 1,1\& 2,\ 2\& 3,\ 3\& 4,\ 4\& 5,\ 5\& 6 \right\}$. Steps 2 and 3 were applied to the genes in each set $\text{S}_{\text{ф}}$ individually.

#### 2. Clustering {#sec3.4.7.2}

The expression values from the TMO5 induction from De Rybel et al., 2014 were used as the input data. Clustering of the genes in$\text{~S}_{\text{ф}}$ was implemented by using the Silhouette index followed by linkage clustering. This resulted in a division of the $\text{S}_{\text{ф}}$genes in $\text{c~}$clusters.

#### 3. GRN inference {#sec3.4.7.3}

*3.1. Inferring intra-cluster connections for each cluster* $C_{n}$, *for* $n \in \left\lbrack {1,c} \right\rbrack$*:* The expression values in the TMO5/LHW induction time course for all genes in cluster $\text{C}_{\text{n}}\ $were used as the input data.

*3.1.1 Selecting potential regulators:* A gene $g_{r}$ was selected as a potential regulator of a target gene $g_{s}$ (denoted $\left. g_{r}\ \rightharpoonup g_{s} \right.$) if it exhibited a $\pm p \times g_{r}$ change of expression immediately prior a change of expression of $g_{s}$of $\pm p \times g_{s}$:$$\left. \text{g}_{\text{r}}\ \rightharpoonup\text{g}_{\text{s}}\ \leftrightarrow\ \left( {\text{g}_{\text{r}}\left( \text{t} \right) > \left( {1 + p} \right) \times \text{g}_{\text{r}}\left( {\text{t} - 1} \right)\left| \text{g}_{\text{r}} \right.\left( \text{t} \right) < \left( {1 - p} \right) \times \text{g}_{\text{r}}\left( {\text{t} - 1} \right)} \right)\ \&\ \left( {\text{g}_{\text{s}}\left( {\text{t~} + \ 1} \right)\  > \left( {1 + p} \right)\  \times \ \text{g}_{\text{s}}\left( \text{t} \right)\left| \text{g}_{\text{s}} \right.\left( {\text{t~} + \ 1} \right)\  < \ \left( {1 - p} \right)\  \times \ \text{g}_{\text{s}}\left( \text{t} \right)} \right)\  \right.$$where we set a low threshold $\left( {\text{p} = 0.1} \right)$ to ensure that no regulators were missed.

*3.1.2. DBN modeling:* The GRN inference step was implemented as a Dynamic Bayesian Network (DBN) learning problem, where the dependences among the variables (genes) can be derived over adjacent time steps. Assuming stationarity and the genes to be modeled obeyed the first order Markov assumption, the joint probability distribution could be expressed as:$$\text{P}\left( {\text{X}_{1},\ ...,\text{~X}_{\text{m}}} \right) = \prod\limits_{\text{i}}{\text{P}\left( {\text{X}_{\text{i}}\left| {\text{X}_{1},...,\text{~X}_{\text{i} - 1}} \right.} \right)} = \ \prod\limits_{\text{i}}{\text{P}\left( {\text{X}_{\text{i}}\left| {\text{Pa}\left( \text{X}_{\text{i}} \right)} \right.} \right)}$$where $\text{X}_{\text{i}}$ is the expression of gene $\text{i}$, $\text{m~} = \text{~n}\left( {\text{T~}–\ 1} \right)$ is the number of genes (nodes), and $\text{Pa}\left( \text{X}_{\text{i}} \right)$ is the set of regulators of gene $\text{i}$ (parents of node $\text{i}$).

Given some observations of the variables over time, the DBN estimation was implemented by finding the structure of (2) that maximized the Bayesian Dirichlet equivalence uniform (BDeu) score \[[@bib3]\]. Since the BDeu score of a DBN can be decomposed as the sum of the scores of the log conditional probabilities of each node, the log of the BDeu, BDeul, was used:$$\text{BDeu}_{\text{l}}\left( {\text{D},\text{G}} \right) = \log\left( {\text{P}\left( \text{G} \right)} \right) + \sum\limits_{\text{i} = 1}^{\text{n}}{\sum\limits_{\text{j} = 1}^{\text{q}_{\text{i}}}\left( {\log\left( \frac{\text{Г}\left( \frac{\text{б}}{\text{q}_{\text{i}}} \right)}{\text{Г}\left( {\sum_{\text{k} = 1}^{\text{r}_{\text{i}}}\text{N}_{\text{ijk}}\  + \frac{\text{б}}{\text{q}_{\text{i}}}} \right)} \right)} \right)} + \sum\limits_{\text{k} = 1}^{\text{r}_{\text{i}}}{\text{log}\left( \frac{\text{Г}\left( {\text{N}_{\text{ijk}}\  + \ \frac{\text{б}}{\text{q}_{\text{i}}}} \right)}{\text{Г}\left( \frac{\text{б}}{\text{r}_{\text{i}}\text{q}_{\text{i}}} \right)} \right)}$$where $\text{G}$ refers to the Bayesian graph, $\text{D}$ refers to the dataset containing the observations of the system, $\text{N}_{\text{ijk}}$ indicates the number of data vectors in which gene $\text{i}$,$\text{X}_{\text{i}}$, has the value $\text{k}$ while its parents are in the $\text{jth}$ configuration, and $\text{б}$ refers to the hyperparameters of the Dirichlet distribution.

From (2) and (3), the problem of deriving the DBN can be decomposed into finding the parents for each node. For this, the expression values of each gene were discretized in 2 levels (high and low). Then, for each gene, a list of all possible subsets of potential regulators was generated. To lower the complexity of the algorithm, which increases exponentially with the number of genes, the maximum size allowed for any subset (maximum number of regulators of a gene) was set to 3. The $\text{BDeu}_{\text{l}}\ $was used to evaluate the likelihood that each gene was due to each subset of potential regulators. The regulators of gene $\text{i}$ were selected as the ones contained in the subset that led to the highest value of the $\text{BDeu}_{\text{l}}\ $.

*3.2. Inferring inter-cluster connections:* Steps 3.1.1-3.1.2 were repeated for all hubs (cluster node with the largest degree of edges leaving the node (out-degree)) in all clusters Cn, for n ∈ \[1,c\]. This resulted in inter-cluster interactions among the cluster hubs.

*3.3. Determining the sign of the interactions:* A score was implemented to estimate whether the inferred interactions (edges) were activations or repressions. The score was calculated for each edge as the conditional probability that a gene is expressed (or not expressed) given that a parent was expressed (not expressed) in the prior time point, relative to the probability that a gene is expressed (or not expressed) given that a parent was not expressed (or vice versa expressed) in the prior time point. If the first conditional probability is larger (or smaller) than the second one, then the parent was found to be an activator (or repressor). In the case of a tight, the edge was found to have an undetermined sign.

The application of GENIST with this data resulted in 6 networks, corresponding to the 6 sets of DEGs,$\text{~S}_{\text{ф}}$. To illustrate the cascade of regulations through time, the networks for each set were jointly visualized in Cytoscape \[[@bib45]\]. The final network has 237 nodes, corresponding to the 237 DEGs, and 532 edges (regulations). The thickness each edge correlates with the probability with which the corresponding regulation was calculated (as in (3)), and the size of each node correlates with the number of genes that it directly regulates. The predicted most important regulators can be identified as the largest nodes in the network. The network depicts the time cascade by color-coding the regulations inferred in the different time points: red (0.5-1), green (1-2), blue (2-3), yellow (3-4), pink (4-5), orange (5-6) hours. Overall, the network places the initial time points at the center, and shows how the cascade of regulations expands outward over time.

Quantification and Statistical Analysis {#sec3.5}
---------------------------------------

All violin plots were generated using the BoxPlotR webtool using standard settings (<http://shiny.chemgrid.org/boxplotr>). In all plots, center lines represent the medians; box limits indicate the 25th and 75th percentiles as determined by R software; whiskers extend 1.5 times the interquartile range from the 25th and 75th percentiles, outliers are represented by dots. The number of samples analyzed is indicated on the top of the x axis for each sample when relevant. In the quantification of IPC cell number, one single outlier was removed before statistical analysis. Pairwise comparisons were performed using standard two-sided Student t testing. In all cases, ^∗^ indicates a p value \< 0.05 and ^∗∗^ indicates a p value \< 0.001. In case of multiple samples, a one-way ANOVA analysis with post hoc Tukey HSD testing was performed. Significantly different groups (p value \< 0.001) of samples are indicated using lower case letters.

Data and Software Availability {#sec3.6}
------------------------------

The transcriptomics data files are deposited on the Gene Expression Omnibus (accession number GEO: [GSE116858](ncbi-geo:GSE116858){#intref0120}).

Supplemental Information {#app2}
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Document S1. Figures S1--S4Table S1. 237 Differentially Expressed Genes in the dGR Dataset, Related to Figure 1Table S2. Comparison of the Transcriptome Data and qRT-PCR Validation for 25 Genes, Related to Figure 1Root tips were used for qRT-PCR validation. FC: fold change, p: p value. Color scale indicates fold change of 0.5 (red), 1 (yellow) and 2 (green). Black text indicates time points used for both the transcriptomics analysis and the qRT-PCR validation. The gray text indicates time points only used for transcriptomics analysisData S1. Primers Used in This Study and Number of Lines Screened for Each Construct Used in This Study, Related to Figures 1, 2, 3, and 4Data S2. Analysis of the Predicted Regulations for the Entire Network and the Subnetwork Involving TMO5, ARR12, and DOF2.1, Related to Figure 1Included are the source (the gene predicted to regulate the targets), target (genes predicted to be regulated), edge weight (represented by thickness of the edges in Figure S2), the regulation sign (1 for positive predicted regulation; −1 for negative predicted regulation and 0 for sign not determined) and the time-point at which this regulation is predicted to occurDocument S2. Article plus Supplemental Information
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